Continuum Advisory, LLC Gilead Sciences, Inc. Transaction History

Continuum Advisory, LLC

$778 Million
Q3 2024

A detailed history of Continuum Advisory, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 4,634 shares of GILD stock, worth $435,364. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,634

Previous 4,655 0.45%

Holding current value

$435,364

Previous $319,000 21.63%

% of portfolio

0.05%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$66.59 - $83.99 $1,398 - $1,763	-21 Reduced 0.45%	4,634 $388,000
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $27,912 - $32,212	-442 Reduced 8.67%	4,655 $319,000
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $636,632 - $776,357	-8,894 Reduced 63.57%	5,097 $373,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $39,492 - $44,785	539 Added 4.01%	13,991 $1.13 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $9,242 - $10,083	-125 Reduced 0.92%	13,452 $1.01 Million
Q2 2023 Dec 13, 2023	SELL	$76.01 - $86.7 $436,297 - $497,658	-5,740 Reduced 29.71%	13,577 $1.05 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $436,297 - $497,658	-5,740 Reduced 29.71%	13,577 $1.05 Million
Q1 2023 Dec 13, 2023	SELL	$77.31 - $88.08 $60,379 - $68,790	-781 Reduced 3.89%	19,317 $1.6 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $60,379 - $68,790	-781 Reduced 3.89%	19,317 $1.6 Million
Q4 2022 Dec 13, 2023	BUY	$62.32 - $89.47 $47,612 - $68,355	764 Added 3.95%	20,098 $1.73 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $47,612 - $68,355	764 Added 3.95%	20,098 $1.73 Million
Q3 2022 Dec 13, 2023	BUY	$59.54 - $68.01 $39,653 - $45,294	666 Added 3.57%	19,334 $1.19 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $39,653 - $45,294	666 Added 3.57%	19,334 $1.19 Million
Q2 2022 Dec 13, 2023	BUY	$57.72 - $65.01 $241,673 - $272,196	4,187 Added 28.91%	18,668 $1.15 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $241,673 - $272,196	4,187 Added 28.91%	18,668 $1.15 Million
Q1 2022 Dec 13, 2023	BUY	$57.92 - $72.58 $599,240 - $750,912	10,346 Added 250.21%	14,481 $860,000
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $838,739 - $1.05 Million	14,481 New	14,481 $859,000
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $279,898 - $301,979	-4,135 Closed	0 $0
Q2 2021 Dec 13, 2023	SELL	$63.47 - $69.35 $591,349 - $646,133	-9,317 Reduced 69.26%	4,135 $284,000
Q2 2021 Aug 17, 2021	SELL	$63.47 - $69.35 $10,726 - $11,720	-169 Reduced 3.93%	4,135 $285,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $44,340 - $50,591	-739 Reduced 14.65%	4,304 $283,000
Q3 2020 May 17, 2021	SELL	$62.1 - $78.08 $91,535 - $115,089	-1,474 Reduced 22.62%	5,043 $319,000
Q2 2020 May 18, 2021	BUY	$72.34 - $84.0 $115,526 - $134,148	1,597 Added 32.46%	6,517 $496,000
Q1 2020 May 18, 2021	BUY	$62.63 - $80.22 $308,139 - $394,682	4,920 New	4,920 $357,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Gilead Sciences, Inc. Transaction History